1
|
MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.
|
J Natl Cancer Inst
|
2000
|
3.44
|
2
|
Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.
|
Cancer Res
|
2001
|
2.28
|
3
|
Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.
|
J Clin Endocrinol Metab
|
1995
|
1.88
|
4
|
Tissue-specific synthesis and oxidative metabolism of estrogens.
|
J Natl Cancer Inst Monogr
|
2000
|
1.60
|
5
|
Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers.
|
Breast Cancer Res Treat
|
2000
|
1.39
|
6
|
The effect of chronic childhood malnutrition on pubertal growth and development.
|
Am J Clin Nutr
|
1982
|
1.22
|
7
|
In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
|
J Clin Endocrinol Metab
|
1984
|
1.20
|
8
|
Bioavailability of albumin-bound testosterone.
|
J Clin Endocrinol Metab
|
1985
|
1.10
|
9
|
Timed urinary gonadotropin measurements in normal infants, children, and adults, and in patients with disorders of sexual maturation.
|
J Pediatr
|
1977
|
1.10
|
10
|
Stromal spindle cells contain aromatase in human breast tumors.
|
J Clin Endocrinol Metab
|
1994
|
1.02
|
11
|
Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible?
|
J Steroid Biochem Mol Biol
|
1997
|
1.00
|
12
|
Estrone sulfate: a potential source of estradiol in human breast cancer tissues.
|
Breast Cancer Res Treat
|
1986
|
1.00
|
13
|
Aromatase activity in primary and metastatic human breast cancer.
|
Cancer
|
1987
|
0.92
|
14
|
Biological significance of aromatase activity in human breast tumors.
|
J Clin Endocrinol Metab
|
1983
|
0.91
|
15
|
Prognostic value of breast cancer aromatase.
|
Cancer
|
1992
|
0.90
|
16
|
Aromatase inhibitor development for treatment of breast cancer.
|
Breast Cancer Res Treat
|
1995
|
0.90
|
17
|
Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
|
Br J Cancer
|
1985
|
0.87
|
18
|
Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the rat.
|
Breast Cancer Res Treat
|
1998
|
0.86
|
19
|
A model for validation of radioimmunoassay kit reagents: measurement of follitropin and lutropin in blood and urine.
|
Clin Chem
|
1981
|
0.85
|
20
|
Regulated CYP19 aromatase transcription in breast stromal fibroblasts.
|
J Clin Endocrinol Metab
|
2000
|
0.84
|
21
|
Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies.
|
Am J Dis Child
|
1983
|
0.84
|
22
|
In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
|
Cancer Res
|
1982
|
0.84
|
23
|
Circadian rhythms in gonadotropin excretion in prepubertal and pubertal children.
|
J Clin Endocrinol Metab
|
1976
|
0.80
|
24
|
Determinants of tissue estradiol levels and biologic responsiveness in breast tumors.
|
Breast Cancer Res Treat
|
1998
|
0.80
|
25
|
Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
|
Ann N Y Acad Sci
|
1986
|
0.78
|
26
|
Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
|
J Steroid Biochem
|
1984
|
0.78
|
27
|
Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole.
|
J Clin Endocrinol Metab
|
1995
|
0.78
|
28
|
17 Beta-hydroxysteroid dehydrogenase in human breast cancer: analysis of kinetic and clinical parameters.
|
Steroids
|
1989
|
0.78
|
29
|
Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase.
|
J Steroid Biochem Mol Biol
|
1996
|
0.78
|
30
|
Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
|
Anticancer Res
|
1984
|
0.78
|
31
|
Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals.
|
J Clin Endocrinol Metab
|
1982
|
0.77
|
32
|
Correlation of aromatase activity with histological differentiation of breast cancer--a morphometric analysis.
|
Breast Cancer Res Treat
|
1988
|
0.77
|
33
|
Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: role of very high affinity tissue uptake.
|
Breast Cancer Res Treat
|
1997
|
0.76
|
34
|
Role of polyamines in the synthesis of prolactin-regulated growth factors by experimental breast cancer in culture.
|
Breast Cancer Res Treat
|
1987
|
0.76
|
35
|
Gonadotropin excretion during puberty in malnourished children.
|
J Pediatr
|
1984
|
0.75
|
36
|
Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
|
J Lab Clin Med
|
1987
|
0.75
|
37
|
Potency and specificity of CGS-16949A as an aromatase inhibitor.
|
Endocr Res
|
1990
|
0.75
|
38
|
Marked heterogeneity of aromatase activity in human malignant melanoma tissue.
|
Eur J Cancer Clin Oncol
|
1988
|
0.75
|
39
|
Three-component model of oestrogen formation and regulation of intratumoural oestrogen pool in breast neoplasms.
|
Med Hypotheses
|
1995
|
0.75
|
40
|
Response of the prepubertal ovary to acute chorionic gonadotropin administration: absence of modulation by growth hormone.
|
J Clin Endocrinol Metab
|
1985
|
0.75
|
41
|
Perturbations of negative feedback sensitivity in agonadal patients undergoing estrogen replacement therapy.
|
J Clin Endocrinol Metab
|
1983
|
0.75
|
42
|
The integrated gonadotrophin test.
|
Ann Intern Med
|
1978
|
0.75
|
43
|
Inhibition of testosterone production with ketoconazole alone and in combination with a gonadotropin releasing hormone analogue in the rat.
|
Cancer Res
|
1986
|
0.75
|
44
|
Urinary follicle-stimulating hormone during pregnancy: relationship to sex of fetus.
|
J Clin Endocrinol Metab
|
1979
|
0.75
|
45
|
Pseudoaromatase in circulating lymphocytes.
|
J Steroid Biochem Mol Biol
|
1993
|
0.75
|
46
|
The assessment of diminished testicular function in boys of pubertal age.
|
Clin Endocrinol (Oxf)
|
1986
|
0.75
|
47
|
Usefulness of urinary gonadotropin measurements to assess luteinizing hormone releasing factor (LRF) responsiveness in hypogonadotropic states.
|
J Clin Endocrinol Metab
|
1977
|
0.75
|